Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma.

Asano Y, Veatch JR, Sung CJ, Tang TH, Mazziotta F, Natsuki S, McAfee M, Bakhtiari J, Lee B, Martin L, Rizzi A, Zhang T, Smith CW, Paulson KG, Schmitt TM, Newell EW, Elz AE, Chen DG, Su Y, Gustafson HH, Yeung CCS, Seaton B, Hunter D, Koelle DM, Bhatia S, Hall ET, Voillet V, Cao J, Gooley T, Greenberg PD, Gottardo R, Oda SK, Nghiem P, Chapuis AG.

Open source

DOI: 10.1126/scitranslmed.aea8773
Published: 2026-09-09
Container: Sci Transl Med
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1126/scitranslmed.aea8773,
  title = {Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma.},
  author = {Asano Y and  Veatch JR and  Sung CJ and  Tang TH and  Mazziotta F and  Natsuki S and  McAfee M and  Bakhtiari J and  Lee B and  Martin L and  Rizzi A and  Zhang T and  Smith CW and  Paulson KG and  Schmitt TM and  Newell EW and  Elz AE and  Chen DG and  Su Y and  Gustafson HH and  Yeung CCS and  Seaton B and  Hunter D and  Koelle DM and  Bhatia S and  Hall ET and  Voillet V and  Cao J and  Gooley T and  Greenberg PD and  Gottardo R and  Oda SK and  Nghiem P and  Chapuis AG.},
  year = {2026},
  journal = {Sci Transl Med},
  doi = {10.1126/scitranslmed.aea8773},
  url = {https://doi.org/10.1126/scitranslmed.aea8773}
}

RIS

TY  - JOUR
TI  - Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma.
AU  - Asano Y
AU  -  Veatch JR
AU  -  Sung CJ
AU  -  Tang TH
AU  -  Mazziotta F
AU  -  Natsuki S
AU  -  McAfee M
AU  -  Bakhtiari J
AU  -  Lee B
AU  -  Martin L
AU  -  Rizzi A
AU  -  Zhang T
AU  -  Smith CW
AU  -  Paulson KG
AU  -  Schmitt TM
AU  -  Newell EW
AU  -  Elz AE
AU  -  Chen DG
AU  -  Su Y
AU  -  Gustafson HH
AU  -  Yeung CCS
AU  -  Seaton B
AU  -  Hunter D
AU  -  Koelle DM
AU  -  Bhatia S
AU  -  Hall ET
AU  -  Voillet V
AU  -  Cao J
AU  -  Gooley T
AU  -  Greenberg PD
AU  -  Gottardo R
AU  -  Oda SK
AU  -  Nghiem P
AU  -  Chapuis AG.
PY  - 2026
JO  - Sci Transl Med
DO  - 10.1126/scitranslmed.aea8773
UR  - https://doi.org/10.1126/scitranslmed.aea8773
ER  -

APA

Y, A., JR, V., CJ, S., TH, T., F, M., S, N., M, M., J, B., B, L., L, M., A, R., T, Z., CW, S., KG, P., TM, S., EW, N., AE, E., DG, C., Y, S., HH, G., CCS, Y., B, S., D, H., DM, K., S, B., ET, H., V, V., J, C., T, G., PD, G., R, G., SK, O., P, N., & AG., C. (2026). Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma.. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aea8773

Source records

europe-pmc · retrieved 2026-09-25T17:39:51.091Z